tirzepatide dose schedule Dosage Chart & Dosing Guide for Weight Loss Tirzepatide Dosage Chart for Weight

In the SURMOUNT-5 head-to-head trial, tirzepatide achieved 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks

Injection site reactions Some people experience more injection site reactions with tirzepatide than they did with semaglutide

Package/Label Display Panel 0.25 mg/0.5 mL Syringe NDC XXXX-XXXX-XX List XXXXXX Ozempic 0.25 mg (semaglutide) injection 0.25 mg/0.5 mL Use Ozempic 1 time a week For subcutaneous use only Each prefilled syringe delivers 0.25 mg semaglutide Rx only Dispense the enclosed Medication Guide to each patient

Provider communication throughout the switching and potential switching-back process is essential